CVR: 38768964
Innosurge Biologics A/S is a Danish company of the type Aktieselskab based in Randers NV, founded in 2017. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Peter Møller Lassen. The company is owned by CMA HOLDING RANDERS ApS. The company has 1 employee. In 2025, the company reported a gross profit of DKK 4,455,235 and a net result of DKK 1,662,593 compared with DKK 251,617 the year before. Equity amounted to DKK 2,897,096.
Your company? Claim the profile and show your logo, website and social channels — for free.
Claim this profileSelskabets formål er at drive virksomhed med engroshandel med læge- og hospitalsartikler og hermed forbundet virksomhed.
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 4.5 mio. | 1.7 mio. | 5.7 mio. | 2.9 mio. | 2 | |
| 2024 | 2.4 mio. | 252 t. | 3.6 mio. | 2 mio. | 2 | |
| 2023 | 2.1 mio. | 407 t. | 4.7 mio. | 1.7 mio. | 2 | |
| 2022 | 2.2 mio. | 490 t. | 4.6 mio. | 1.3 mio. | 3 | |
| 2021 | 993 t. | -613 t. | 3.8 mio. | 836 t. | 3 | |
| 2020 | -695 t. | -2.6 mio. | 3.1 mio. | 1.4 mio. | 3 | |
| 2019 | 1.2 mio. | 290 t. | 4.3 mio. | 2 mio. | 2 | |
| 2018 | 1.7 mio. | 799 t. | 5 mio. | 1.8 mio. | 1 |
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorCompared to 294 companies in Engroshandel med læge- og hospitalsartikler
Comparison is based on industry median values
Innosurge Biologics A/S has published its annual report for 2025. Gross profit came to DKK 4,455,235, and the net result was DKK 1,662,593.
Innosurge Biologics A/S has published its annual report for 2024. Gross profit came to DKK 2,444,975, and the net result was DKK 251,617.
Innosurge Biologics A/S has published its annual report for 2023. Gross profit came to DKK 2,077,814, and the net result was DKK 406,817.
As of October 1, 2023, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Innosurge Biologics A/S.
As of October 1, 2023, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has stepped down as auditor of Innosurge Biologics A/S.
Innosurge Biologics A/S has published its annual report for 2022. Gross profit came to DKK 2,183,245, and the net result was DKK 489,687.
Innosurge Biologics A/S has published its annual report for 2021. Gross profit came to DKK 992,732, and the net result was DKK -613,437.
Innosurge Biologics A/S has published its annual report for 2020. Gross profit came to DKK -695,490, and the net result was DKK -2,600,178.
Innosurge Biologics A/S has published its annual report for 2019. Gross profit came to DKK 1,241,663, and the net result was DKK 290,106.
As of April 20, 2020, Heinz Kvottrup Lorentzen has joined the board of directors of Innosurge Biologics A/S.
As of April 20, 2020, Svend Aage Jensen has left the board of directors of Innosurge Biologics A/S.
As of April 19, 2020, Heinz Kvottrup Lorentzen has left the board of directors of Innosurge Biologics A/S.
Innosurge Biologics A/S has published its annual report for 2018. Gross profit came to DKK 1,740,667, and the net result was DKK 799,342.
Innosurge Biologics A/S has published its interim report for the period June 23, 2017 – December 31, 2017.
As of October 17, 2017, Svend Aage Jensen has joined the board of directors of Innosurge Biologics A/S.
As of October 17, 2017, Heinz Kvottrup Lorentzen has joined the board of directors of Innosurge Biologics A/S.
As of October 17, 2017, Peter Møller Lassen is registered as adm. dir. of Innosurge Biologics A/S.
As of October 16, 2017, Heinz Kvottrup Lorentzen has left the board of directors of Innosurge Biologics A/S.
As of October 16, 2017, Peter Møller Lassen has stepped down as director of Innosurge Biologics A/S.
As of June 23, 2017, Kvist & Jensen Statsautoriseret Revisionspartnerselskab has been appointed auditor of Innosurge Biologics A/S.
As of June 23, 2017, Heinz Kvottrup Lorentzen has joined the board of directors of Innosurge Biologics A/S.
As of June 23, 2017, Michael Maigaard Nielsen has joined the board of directors of Innosurge Biologics A/S.
As of June 23, 2017, Peter Møller Lassen has joined the board of directors of Innosurge Biologics A/S.
As of June 23, 2017, Peter Møller Lassen is registered as director of Innosurge Biologics A/S.
As of June 23, 2017, CMA HOLDING RANDERS ApS is registered as an owner of Innosurge Biologics A/S with an ownership share of 100%.
Innosurge Biologics A/S was founded on June 23, 2017.
Companies in the same industry and area
CVR 31492572
CVR 38891308
CVR 44334178
CVR 14653538
CVR 40862676
companydata.dk